Delivery Order SPE2DB20D1109-SPE2DB25FP46K
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,222.90 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ovidrel 250 mcg/0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a single-line delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ovidrel 250 mcg/0.5 mL syringes, with a contract ceiling value of $3,323.09. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025, under a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,017.45, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 21, 2024. The award was made on February 20, 2024, and there was no set-aside...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $2,610.27 to supply OVIDREL 250 MCG/0.5 ML SYRG 0.5ML pharmaceutical products. As the prime contractor, Amerisourcebergen will deliver the specified medications to DLA Troop Support Medical facilities in support of their provision of pharmaceuticals and supplies for military treatment programs. The delivery order was awarded on November 14, 2023 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) Troop Support Medical with pharmaceutical products and medical supplies, primarily in the form of firm fixed price delivery orders. The award, valued at up to $3,964.50, is for the procurement of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical. The contract has an ultimate completion date of March 22, 2024 and was awarded on March...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The award, with a ceiling value of $1,400.60, is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 6, 2025. This award is not designated as a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $3,585.48 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $10,591.46 by the Defense Logistics Agency (DLA) for the supply of OGIVRI 420 mg vials. This competitive, firm fixed-price delivery order was issued on June 5, 2025, with an ultimate completion date of June 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader relationship with the federal government...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $113.49 to Amerisourcebergen Drug Corp Corporate Office Division for the provision of 4561368149 OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. Place of performance will be in Conshohocken, Pennsylvania over the period of June 28-29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp Corporate Office Division, the prime contractor selected to fulfill this requirement...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $16,462.50 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, for the supply of GONAL-F RFF REDI-JECT 900 Unit 1.44ML, a pharmaceutical product. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award selection. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP46KDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for OVIDREL 250 MCG/0.5 ML syringes valued at $1,259.20 with a firm fixed price structure. The award, issued on July 26, 2025, is a non-set-aside competitive contract with an ultimate completion date of July 28, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office operations serving federal medical procurement needs. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime vehicle provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, enabling AmerisourceBergen to fulfill diverse medical supply requirements across multiple therapeutic domains. As one of the major pharmaceutical distributors serving federal military and veteran healthcare systems, the company has demonstrated consistent capability to meet competitive procurement requirements through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/26/25 |